| Aug 13 |
Q2 2024 Pulse Biosciences Inc Earnings Call
|
| Aug 12 |
Pulse Biosciences Inc. (PLSE) Q2 2024 Earnings Call Transcript
|
| Aug 12 |
Pulse Biosciences reports Q2 results
|
| Aug 12 |
Pulse Biosciences Reports Business Updates and Preliminary Second Quarter 2024 Financial Results
|
| Aug 12 |
Pulse Biosciences, Inc. Appoints Paul LaViolette to Its Board of Directors
|
| Aug 9 |
Pulse Biosciences launches first-in-human pulsed field ablation trial
|
| Aug 8 |
Pulse Biosciences, Inc. Announces Successful Treatment of Patients in First-in-Human Study with its Nano-PFA Cardiac Surgery System
|
| Aug 1 |
Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences
|
| Jul 29 |
Pulse Biosciences Schedules Second Quarter 2024 Financial Results Conference Call for August 12, 2024
|
| Jul 9 |
Pulse drops 510(k) plan for PFA device after FDA requests clinical data
|
